CTR20261831 clinical trial report covering HZ-A-018, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07578558 clinical trial report covering Nogapendekin alfa inbakicept-pmln, Phase 2, endpoints, sponsor, geography, readout timing and development white spa

NCT07578337 clinical trial report covering Botensilimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07581210 clinical trial report covering QD202, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07578025 clinical trial report covering Zanzalintinib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20261564 clinical trial report covering Cough Granules, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07581821 clinical trial report covering Anlotinib Dihydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07581834 clinical trial report covering Tamoxifen Citrate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07581912 clinical trial report covering Cetuximab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07579936 clinical trial report covering Recombinant Teriparatide (Salubris), Phase 2, endpoints, sponsor, geography, readout timing and development white s

NCT07579598 clinical trial report covering Sacituzumab tirumotecan, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07580716 clinical trial report covering Leukocyte cell therapy (Enlivex Therapeutics), Phase 2, endpoints, sponsor, geography, readout timing and developme